We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.
- Authors
Golshayan, Ali Reza; George, Saby; Heng, Daniel Y; Elson, Paul; Wood, Laura S; Mekhail, Tarek M; Garcia, Jorge A; Aydin, Hakan; Zhou, Ming; Bukowski, Ronald M; Rini, Brian I
- Abstract
Metastatic renal cell carcinoma (mRCC) with sarcomatoid differentiation is an aggressive disease that is associated with poor outcomes to chemotherapy or immunotherapy. The utility of vascular endothelial growth factor (VEGF)-targeted therapy in patients with this disease is unknown.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Vol 27, Issue 2, p235
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2008.18.0000